Breaking News Instant updates and real-time market news.

CLLS

Cellectis

$16.86

-0.76 (-4.31%)

, FMS

Fresenius Medical

$38.96

-0.45 (-1.14%)

07:43
12/01/16
12/01
07:43
12/01/16
07:43

Deutsche Bank to hold a conference

Pharmaceutical & Healthcare Corporate Day is being held in London, England on December 1.

CLLS

Cellectis

$16.86

-0.76 (-4.31%)

FMS

Fresenius Medical

$38.96

-0.45 (-1.14%)

AZN

AstraZeneca

$26.14

-0.57 (-2.13%)

NVS

Novartis

$68.76

-0.2 (-0.29%)

NVO

Novo Nordisk

$33.60

0.88 (2.69%)

RHHBY

Roche

$27.76

-0.05 (-0.18%)

  • 01

    Dec

  • 03

    Dec

  • 03

    Dec

  • 07

    Dec

  • 16

    Feb

CLLS Cellectis
$16.86

-0.76 (-4.31%)

11/23/16
PIPR
11/23/16
NO CHANGE
PIPR
Piper says CAR-T researchers must heed risks highlighted by Juno news
Piper Jaffray analyst Joshua Schimmer said the CAR-T field has "taken another step back" after Juno Therapeutics (JUNO) put a hold on its JCAR015 trial again due to fatal cerebral edema and cautioned companies exploring these therapies to be mindful of "unnecessarily aggressive development and under-appreciation of the potent and possibly highly toxic nature" of the approach. However, Schimmer expressed his confidence that companies he covers in the CAR-T space - namely bluebird bio (BLUE), Cellectis (CLLS), Celgene (CELG), Bellicum Pharmaceuticals (BLCM), Lion Biotechnologies (LBIO) and NantKwest (NK) - will "respect the power of these platforms and remember patients' lives are more important than stock prices."
10/27/16
LTCO
10/27/16
NO CHANGE
Target $45
LTCO
Buy
Cellectis recent selloff unwarranted, says Ladenburg
Ladenburg Thalmann analyst Wangzhi Li says the recent pullback in shares of Cellectis is unwarranted. The UCART19 Phase 1 trial is dosing patients on schedule, which is a positive sign for the outcome readout of the trial, Li tells investors in a research note. The analyst recommends buying the shares on the pullback and keeps a Buy rating on the name with a $45 price target.
04/05/16
LTCO
04/05/16
INITIATION
Target $45
LTCO
Buy
Cellectis initiated with a Buy at Ladenburg
Ladenburg Thalmann analyst Wangzhi Li started Cellectis with a Buy rating and $45 price target.
08/31/16
PIPR
08/31/16
NO CHANGE
PIPR
Piper's Schimmer unsure of impact from Novartis CAR-T shakeup
Piper Jaffray analyst Joshua Schimmer said he's struggling with the implications of the news that Novartis (NVS) is reportedly eliminating its Cell and Gene Therapy unit as a stand-alone entity, which is primarily focused on development of CAR-T and adoptive immunotherapies. On the one hand, removing a leading competitor is a positive for the rest of the field, Schimmer tells investors in a research note. On the other hand, the move by Novartis could signal "significant challenges" in the field, the analyst adds. Schimmer continues to prefer companies "with unique and differentiated approaches," namely Bellicum Pharmaceuticals (BLCM), Cellectis (CLLS), Lion Biotechnologies (LBIO), Amgen (AMGN), Celgene (CELG) and bluebird bio (BLUE). Juno Therapeutics (JUNO) and Kite Pharma (KITE) are down 6% and 5%, respectively, in midday trading.
FMS Fresenius Medical
$38.96

-0.45 (-1.14%)

10/13/16
RHCO
10/13/16
NO CHANGE
RHCO
Price targets cut on dialysis stocks at SunTrust
SunTrust analyst David MacDonald lowered his price targets on dialysis stocks, citing CMS' recent request for information and resulting payor risk and lower assumed multiples. The analyst cut his price target on American Renal Associates (ARA) to $24 from $34, on DaVita (DVA) to $66 from $80 and on Fresenius Medical (FMS) to $48 from $54. He maintains Buy ratings on American Renal and Fresenius but said he does not expect the stocks to rise significantly until the CMS matter is resolved. MacDonald keeps a Hold rating on DaVita.
09/06/16
SBSH
09/06/16
INITIATION
SBSH
Buy
Fresenius Medical initiated with a Buy at Citi
Price target EUR 98.
09/06/16
SBSH
09/06/16
INITIATION
Target $71
SBSH
Neutral
DaVita initiated with a Neutral at Citi
Citi analyst Patrick Wood started DaVita Healthcare Partners (DVA) with a Neutral rating and $71 price target. The analyst sees limited upside to consensus estimates and prefers Fresenius Medical Care (FMS) at current share levels.
07/08/16
JEFF
07/08/16
UPGRADE
JEFF
Hold
Fresenius Medical upgraded to Hold from Underperform at Jefferies
Jefferies analyst Chris Cooper upgraded Fresenius Medical to Hold with a EUR 81 price target.
AZN AstraZeneca
$26.14

-0.57 (-2.13%)

11/09/16
SBSH
11/09/16
NO CHANGE
SBSH
Citi sees Healthcare 'relief rally' after Trump win
Citi analyst Andrew Baum expects a "'relief rally" to drive near-term sector outperformance for names in the Healthcare space given the "inability of the Democrats to attain the Presidency, the House or Congress." Longer term, however, the analyst still sees "significant continued legislative risk" for pharma reimbursement. Baum prefers GlaxoSmithKline (GSK), AstraZeneca (AZN), Shire (SHPG) and Roche (RHHBY) among European majors and Bristol-Myers (BMY) and Eli Lilly (LLY) in the U.S.
10/26/16
PIPR
10/26/16
NO CHANGE
PIPR
Neutral
Piper still uncertain on Clovis position after AstraZeneca data
AstraZeneca's (AZN) Phase III study of Lynparza in ovarian cancer "substantially improved" progression-free survival over what was seen in study 19, suggesting a profile at least similar to TESARO's (TSRO) niraparib, Piper Jaffray analyst Steven Breazzano tells investors in a research note. The new data confirm that the various PARP inhibitors are more similar than different, which bodes well for Clovis Oncology's (CLVS) own maintenance study, the analyst contends. Breazzano, however, remains the sidelines with respect to Clovis shares given the "increasingly competitive dynamic" in ovarian cancer and uncertainty in the company's position in the important maintenance setting. The analyst keeps a Neutral rating on Clovis.
11/28/16
SBSH
11/28/16
DOWNGRADE
Target $60
SBSH
Neutral
Citi analyst 'perturbed,' downgrades AbbVie to Neutral
Citi analyst Andrew Baum earlier today downgraded AbbVie (ABBV) to Neutral from Buy and lowered his price target for the shares to $60 from $65. The biopharmaceutical company is trading down 2%, or 99c, to $59.52. The risk to post 2017 consensus estimates for Humira has "increased on almost all fronts," Baum tells investors in a research note. The analyst sees increased patent risk and competition from biosimilar Enbrel in Europe. He also believes AstraZeneca (AZN) and Acerta's acalabrutinib "looks like a better mousetrap" than AbbVie's Imbruvica. Baum is also "perturbed" by AbbVie management's recent "rich" acquisition of Stemcentrx. He prefers shares of Eli Lilly (LLY) and Bristol-Myers (BMY) to AbbVie.
10/20/16
JANY
10/20/16
NO CHANGE
Target $1.5
JANY
Neutral
Cerulean cash infusion gives chance to execute on programs, says Janney Capital
Janney Capital analyst Debjit Chattopadhyay said Cerulean's (CERU) collaboration with Novartis (NVS), which comes with a "modest" $5M upfront payment, and its $20M ATM facility with Aspire Capital, while "not ideal," gives management a chance to execute on three of its ongoing programs, the most important of which is the dose escalation study with Olaparib with partner AstraZeneca (AZN) that should have preliminary data in 2Q17. The analyst raised his fair value estimate on Cerulean to $1.50 from $1.00 and keeps a Neutral rating on the stock.
NVS Novartis
$68.76

-0.2 (-0.29%)

11/10/16
ARGS
11/10/16
UPGRADE
ARGS
Buy
Novartis upgraded to Buy from Hold at Argus
10/26/16
LEER
10/26/16
NO CHANGE
Target $80
LEER
Market Perform
Novartis price target lowered to $80 from $89 at Leerink
Leerink analyst Seamus Fernandez lowered his price target for Novartis to $80 from $89 after a "disappointing" Q3 performance despite bottom-line beat. The analyst reiterates a Market Perform rating on the shares.
11/10/16
11/10/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Priceline (PCLN) upgraded to Buy from Hold at Stifel while the firm upgraded Expedia (EXPE) to Hold from Sell. 2. IBM (IBM) upgraded to Buy from Neutral at BofA/Merrill with analyst Wamsi Mohan expecting 2017 profits to grow as earnings have stabilized and negative revisions are unlikely and expects tailwinds from moderating pace of investments and savings from restructuring efforts. 3. L-3 Communications (LLL) and Northrop Grumman (NOC) upgraded to Overweight from Equal Weight at Barclays while the firm upgraded Lockheed Martin (LMT) to Equal Weight from Underweight. 4. Microsoft (MSFT) upgraded to Neutral from Underweight at Atlantic Equities. 5. Novartis (NVS) upgraded to Buy from Hold at Argus. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
11/30/16
RHCO
11/30/16
NO CHANGE
RHCO
GlycoMimetics has positive read through from deal, says SunTrust
SunTrust analyst Yatin Suneja says that Novartis' (NVS) recent acquisition of Selexys Pharmaceuticals "provides further clinical and commercial validation for the selectin class of adhesion molecules as meaningful therapeutic targets." The analyst notes that the acquisition came after Selexys' SelG1, which utilizes a P-selectin antibody, showed positive Phase II data in sickle cell disease. GlycoMimetics (GLYC) develops selectin antagonists. The analyst expects interest in the name to accelerate as more data is announced. Suneja keeps a Buy rating on the shares.
NVO Novo Nordisk
$33.60

0.88 (2.69%)

09/23/16
PIPR
09/23/16
INITIATION
PIPR
Neutral
Novo Nordisk initiated with a Neutral at Piper Jaffray
Piper Jaffray analyst Richard Purkiss started Novo Nordisk with a Neutral rating and DKK 320 price target.
09/13/16
EXAN
09/13/16
UPGRADE
EXAN
Outperform
Novo Nordisk upgraded to Outperform from Neutral at Exane BNP Paribas
10/31/16
SBSH
10/31/16
DOWNGRADE
SBSH
Neutral
Novo Nordisk downgraded to Neutral from Buy at Citi
Citi analyst Peter Verdult downgraded Novo Nordisk to Neutral citing the ongoing net pricing declines across the company's diabetes portfolio as well as expectations for margin erosion at Biopharmaceuticals due to NovoSeven/Norditropin pressures. The analyst cut his price target for the shares to DKK 260 from DKK 400.
10/28/16
BOFA
10/28/16
DOWNGRADE
BOFA
Underperform
Novo Nordisk downgraded to Underperform from Neutral at BofA/Merrill
RHHBY Roche
$27.76

-0.05 (-0.18%)

09/27/16
PIPR
09/27/16
NO CHANGE
Target $62
PIPR
Neutral
Bristol-Myers price target lowered to $62 from $65 at Piper Jaffray
Piper Jaffray analyst Richard Purkiss lowered his price target for Bristol-Myers Squibb (BMY) to $62 saying he sees the company ceding Opdivo's early-mover advantage in lung cancer to competitors. The analyst expects to see details from Roche's (RHHBY) positive OAK trial of Tecentriq vs. docetaxel in non-small cell lung cancer at the upcoming ESMO meeting. Purkiss also expects to see details from Merck's (MRK) positive KEYNOTE-024 trial of Keytruda. The analyst lowered his post-2016 Opdivo forecasts and reiterates a Neutral rating on Bristol shares.
10/19/16
LEER
10/19/16
NO CHANGE
LEER
Roche Tecentriq approval increases competition, says Leerink
Leerink analyst Seamus Fernandez says that the FDA approval of Roche's (RHHBY) Tecentriq in second-line non-small cell lung cancer patients regardless of PD-L1 expression comes as no surprise given its previously reported overall survival advantage. Nonetheless, the analyst believes it creates new competition for Bristol-Myers' (BMY) Opdivo and Merck's (MRK) Keytruda in this setting.
09/12/16
JEFF
09/12/16
NO CHANGE
Target $57
JEFF
Hold
Jefferies cuts Bristol-Myers price target, upgrades AstraZeneca
Jefferies analyst Jeffrey Holford lowered his price target for Bristol-Myers Squibb (BMY) to $57 from $69 saying the stock is positioned for a "rough mid term ride." The analyst sees a "difficult catalyst" set for Bristol shares with "numerous" upcoming competitor read-outs in non-small cell lung cancer. The market could see worse than expected data from Bristol's CM-026 and CM-568 studies as well as better than expected data from AstraZeneca's (AZN) MYSTIC study and Roche's (RHHBY) Chemo-IO studies in the first half of 2017, Holford tells investors in a research note. He keeps a Hold rating on Bristol and upgraded this morning AstraZeneca to Buy from Hold. Holford prefers Astra for its immunology exposure.

TODAY'S FREE FLY STORIES

TSLA

Tesla

$314.07

5.44 (1.76%)

18:28
04/30/17
04/30
18:28
04/30/17
18:28
Periodicals
SolarCity to curtail door-to-door sales tactic, Reuters says »

Tesla's SolarCity is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

  • 30

    May

DIS

Disney

$115.60

-0.24 (-0.21%)

, CMCSA

Comcast

$39.19

-0.4 (-1.01%)

18:16
04/30/17
04/30
18:16
04/30/17
18:16
Periodicals
Hulu likely to unveil cable bundle at end of May, NY Post says »

Hulu will likely unveil…

DIS

Disney

$115.60

-0.24 (-0.21%)

CMCSA

Comcast

$39.19

-0.4 (-1.01%)

CMCSK

Comcast

FOX

21st Century Fox

$29.86

-0.07 (-0.23%)

FOXA

21st Century Fox

$30.54

-0.02 (-0.07%)

TWX

Time Warner

$99.27

-0.63 (-0.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

  • 08

    May

  • 10

    May

  • 15

    Jun

TCEHY

Tencent

$31.35

-0.11 (-0.35%)

, FB

Facebook

$150.25

2.55 (1.73%)

17:52
04/30/17
04/30
17:52
04/30/17
17:52
Periodicals
Tencent plans to launch VR headset later this year, FT says »

Tencent (TCEHY) is…

TCEHY

Tencent

$31.35

-0.11 (-0.35%)

FB

Facebook

$150.25

2.55 (1.73%)

SSNLF

Samsung

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

  • 08

    May

  • 16

    May

CYH

Community Health

$8.61

0.18 (2.14%)

, HCA

HCA Holdings

$84.21

0.77 (0.92%)

17:49
04/30/17
04/30
17:49
04/30/17
17:49
Hot Stocks
Pence: 'Hope' to replace Obamacare before year end »

Speaking in an NBC…

CYH

Community Health

$8.61

0.18 (2.14%)

HCA

HCA Holdings

$84.21

0.77 (0.92%)

LPNT

LifePoint

$62.15

1.4 (2.30%)

THC

Tenet

$15.67

0.2 (1.29%)

UHS

Universal Health

$120.76

2.55 (2.16%)

UNH

UnitedHealth

$174.88

0.25 (0.14%)

KND

Kindred Healthcare

$9.60

0.25 (2.67%)

VTR

Ventas

$64.01

-0.11 (-0.17%)

AET

Aetna

$135.07

1.09 (0.81%)

ANTM

Anthem

$177.89

-0.41 (-0.23%)

CI

Cigna

$156.37

0.16 (0.10%)

HUM

Humana

$221.98

3.31 (1.51%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

  • 02

    May

  • 02

    May

  • 02

    May

  • 03

    May

  • 03

    May

  • 04

    May

  • 05

    May

  • 16

    May

  • 18

    May

  • 18

    May

  • 24

    May

  • 31

    May

  • 06

    Jun

  • 13

    Jun

DAL

Delta Air Lines

$45.44

-0.3 (-0.66%)

17:25
04/30/17
04/30
17:25
04/30/17
17:25
Periodicals
Delta pilot returns to duty after possibly striking brawling woman, NYT says »

A Delta pilot who stepped…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 30

    Jun

TSLA

Tesla

$314.07

5.44 (1.76%)

17:13
04/30/17
04/30
17:13
04/30/17
17:13
Hot Stocks
Tesla CEO hints at plans for additional Gigafactories »

The TED organization has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

  • 30

    May

TSLA

Tesla

$314.07

5.44 (1.76%)

17:03
04/30/17
04/30
17:03
04/30/17
17:03
Periodicals
Tesla CEO releases teaser image of semi truck, Fortune says »

During a "TED"…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

  • 30

    May

CMCSA

Comcast

$39.19

-0.4 (-1.01%)

, CMCSK

Comcast

16:47
04/30/17
04/30
16:47
04/30/17
16:47
Hot Stocks
Box Office Battle: 'Furious' crosses $1B as 'Guardians Of Galaxy' preps launch »

Comcast's (CMCSA)…

CMCSA

Comcast

$39.19

-0.4 (-1.01%)

CMCSK

Comcast

LGF.A

Lionsgate

$26.17

-0.11 (-0.42%)

LGF.B

Lionsgate

$23.85

-0.15 (-0.63%)

FOX

21st Century Fox

$29.86

-0.07 (-0.23%)

FOXA

21st Century Fox

$30.54

-0.02 (-0.07%)

DIS

Disney

$115.60

-0.24 (-0.21%)

SNE

Sony

$34.52

0.8 (2.37%)

TWX

Time Warner

$99.27

-0.63 (-0.63%)

VIA

Viacom

$44.60

-0.8 (-1.76%)

VIAB

Viacom

$42.56

-0.75 (-1.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

  • 04

    May

  • 08

    May

  • 10

    May

  • 24

    May

  • 25

    May

  • 15

    Jun

ELLO

Ellomay Capital

$8.05

0.0019 (0.02%)

14:33
04/30/17
04/30
14:33
04/30/17
14:33
Hot Stocks
Ellomay Capital enters agreement to acquire Talasol Solar »

Ellomay Capital announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLPG

Galapagos NV

$86.86

0.87 (1.01%)

14:23
04/30/17
04/30
14:23
04/30/17
14:23
Hot Stocks
Galapagos presents preclinical data on osteoarthritis candidate GLPG1972 »

Galapagos announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

  • 06

    Jun

SO

Southern Company

$49.80

-0.27 (-0.54%)

, TOSBF

Toshiba, also use TOSYY

$2.03

0.06 (3.05%)

14:16
04/30/17
04/30
14:16
04/30/17
14:16
Hot Stocks
Southern Co subsidiary extends interim agreement for Vogtle nuclear expansion »

Georgia Power and…

SO

Southern Company

$49.80

-0.27 (-0.54%)

TOSBF

Toshiba, also use TOSYY

$2.03

0.06 (3.05%)

TOSYY

Toshiba, also use TOSBF

$12.14

0.25 (2.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

  • 24

    May

CG

Carlyle Group

$17.70

0.2 (1.14%)

14:10
04/30/17
04/30
14:10
04/30/17
14:10
Hot Stocks
Sequa completes recapitalization with participation from Carlyle Group »

Sequa Corp announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IBM

IBM

$160.29

-0.03 (-0.02%)

14:07
04/30/17
04/30
14:07
04/30/17
14:07
Hot Stocks
IBM says granted patent for drone package transfer »

IBM announced Friday that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GRAM

Grana y Montero

$3.37

0.07 (2.12%)

14:05
04/30/17
04/30
14:05
04/30/17
14:05
Hot Stocks
Grana y Montero completes sale of PRINSUR stake for $25M »

Grana y Montero announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KO

Coca-Cola

$43.15

0.14 (0.33%)

13:49
04/30/17
04/30
13:49
04/30/17
13:49
Hot Stocks
Coca-Cola Bottling UNITED says closes Georgia transaction with Coca-Cola »

Coca-Cola Bottling…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    May

VZ

Verizon

$45.91

-0.76 (-1.63%)

, T

AT&T

$39.63

-0.28 (-0.70%)

13:06
04/30/17
04/30
13:06
04/30/17
13:06
Periodicals
Business tax cut would favor telecoms, retailers, other sectors, Barron's says »

Sectors favored under a…

VZ

Verizon

$45.91

-0.76 (-1.63%)

T

AT&T

$39.63

-0.28 (-0.70%)

JPM

JPMorgan

$87.00

-0.61 (-0.70%)

COF

Capital One

$80.38

-1.93 (-2.34%)

CMA

Comerica

$70.70

-0.05 (-0.07%)

GPS

Gap

$26.20

-0.15 (-0.57%)

JWN

Nordstrom

$48.27

-0.03 (-0.06%)

BRK.A

Berkshire Hathaway

$247,780.00

-2170 (-0.87%)

BRK.B

Berkshire Hathaway

$165.21

-1.34 (-0.80%)

ANTM

Anthem

$177.89

-0.41 (-0.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    May

  • 09

    May

  • 09

    May

  • 16

    May

  • 17

    May

  • 17

    May

  • 18

    May

  • 19

    May

  • 31

    May

  • 06

    Jun

  • 14

    Jul

  • 12

    Oct

  • 13

    Apr

  • 13

    Jul

  • 12

    Oct

CMG

Chipotle

$474.47

-7.53 (-1.56%)

12:59
04/30/17
04/30
12:59
04/30/17
12:59
Periodicals
Chipotle remains unattractive, Barron's says »

Investors should continue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ESRX

Express Scripts

$61.34

-0.06 (-0.10%)

, ANTM

Anthem

$177.89

-0.41 (-0.23%)

12:45
04/30/17
04/30
12:45
04/30/17
12:45
Periodicals
Express Scripts contract-loss warning suggests further pain, Barron's says »

Express Scripts'…

ESRX

Express Scripts

$61.34

-0.06 (-0.10%)

ANTM

Anthem

$177.89

-0.41 (-0.23%)

CVS

CVS Health

$82.44

-0.35 (-0.42%)

UNH

UnitedHealth

$174.88

0.25 (0.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

  • 10

    May

  • 18

    May

  • 31

    May

  • 06

    Jun

LITE

Lumentum

$42.75

-1.05 (-2.40%)

, OCLR

Oclaro

$8.01

0.08 (1.01%)

12:38
04/30/17
04/30
12:38
04/30/17
12:38
Periodicals
Bargain-priced fiberoptic space looks attractive, Barron's says »

Fiberoptic stocks…

LITE

Lumentum

$42.75

-1.05 (-2.40%)

OCLR

Oclaro

$8.01

0.08 (1.01%)

NPTN

NeoPhotonics

$7.76

-0.19 (-2.39%)

FNSR

Finisar

$22.84

0.27 (1.20%)

ACIA

Acacia Communications

$45.84

-0.76 (-1.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

  • 04

    May

  • 05

    May

  • 09

    May

  • 09

    May

  • 23

    May

  • 24

    May

  • 25

    May

  • 30

    May

COH

Coach

$39.39

-0.43 (-1.08%)

12:14
04/30/17
04/30
12:14
04/30/17
12:14
Periodicals
Coach could reserve course, Barron's says »

Retail accessory makers…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

EPC

Edgewell Personal Care

$71.49

-0.14 (-0.20%)

, PG

Procter & Gamble

$87.33

-0.36 (-0.41%)

12:08
04/30/17
04/30
12:08
04/30/17
12:08
Periodicals
Bargain-priced Edgewell could attract suitor, Barron's says »

Edgewell Personal Care…

EPC

Edgewell Personal Care

$71.49

-0.14 (-0.20%)

PG

Procter & Gamble

$87.33

-0.36 (-0.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

NEE

NextEra Energy

$133.56

0.04 (0.03%)

11:58
04/30/17
04/30
11:58
04/30/17
11:58
Periodicals
NextEra Energy could return 20% in a year, Barron's says »

NextEra Energy appears…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    May

CAT

Caterpillar

$102.26

-0.42 (-0.41%)

11:52
04/30/17
04/30
11:52
04/30/17
11:52
Periodicals
Caterpillar shares 'back on track' for price gains, Barron's says »

Caterpillar is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    May

  • 14

    Jun

RYN

Rayonier

$28.22

-0.39 (-1.36%)

, LL

Lumber Liquidators

$24.55

0.19 (0.78%)

08:21
04/30/17
04/30
08:21
04/30/17
08:21
Hot Stocks
Week in review: How Trump's policies moved stocks »

Catch up on the top…

RYN

Rayonier

$28.22

-0.39 (-1.36%)

LL

Lumber Liquidators

$24.55

0.19 (0.78%)

DEL

Deltic Timber

$77.37

-2.24 (-2.81%)

WY

Weyerhaeuser

$33.87

-0.8 (-2.31%)

OSB

Norbord

$31.07

0.23 (0.75%)

PCH

Potlatch

$45.05

-1.9 (-4.05%)

UFPI

Universal Forest

$95.29

-1.92 (-1.98%)

AA

Alcoa

$33.73

-0.79 (-2.29%)

KALU

Kaiser Aluminum

$84.41

-0.15 (-0.18%)

CENX

Century Aluminum

$13.64

-0.36 (-2.57%)

NFLX

Netflix

$152.20

-0.88 (-0.57%)

FB

Facebook

$150.25

2.55 (1.73%)

AMZN

Amazon.com

$924.99

6.61 (0.72%)

GOOG

Alphabet

$905.96

31.71 (3.63%)

GOOGL

Alphabet Class A

$924.52

33.08 (3.71%)

CMCSA

Comcast

$39.19

-0.4 (-1.01%)

CMCSK

Comcast

VZ

Verizon

$45.91

-0.76 (-1.63%)

T

AT&T

$39.63

-0.28 (-0.70%)

CYH

Community Health

$8.61

0.18 (2.14%)

HCA

HCA Holdings

$84.21

0.77 (0.92%)

LPNT

LifePoint

$62.15

1.4 (2.30%)

THC

Tenet

$15.67

0.2 (1.29%)

UHS

Universal Health

$120.76

2.55 (2.16%)

AET

Aetna

$135.07

1.09 (0.81%)

ANTM

Anthem

$177.89

-0.41 (-0.23%)

CNC

Centene

$74.40

1.45 (1.99%)

CI

Cigna

$156.37

0.16 (0.10%)

HNT

Health Net

HUM

Humana

$221.98

3.31 (1.51%)

MOH

Molina Healthcare

$49.79

1.16 (2.39%)

UNH

UnitedHealth

$174.88

0.25 (0.14%)

WCG

WellCare

$153.41

0.03 (0.02%)

HRB

H&R Block

$24.79

0.52 (2.14%)

INTU

Intuit

$125.21

-0.4 (-0.32%)

ATW

Atwood Oceanics

$7.83

-0.01 (-0.13%)

DO

Diamond Offshore

$14.42

-0.07 (-0.48%)

NE

Noble Corp.

$4.80

-0.03 (-0.62%)

NADL

North Atlantic Drilling

$2.53

0.18 (7.66%)

PACD

Pacific Drilling

$1.70

-0.07 (-3.95%)

RDC

Rowan Companies

$14.07

0.07 (0.50%)

SDRL

Seadrill

$0.69

0.0221 (3.31%)

FSLR

First Solar

$29.55

0.11 (0.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

  • 01

    May

  • 01

    May

  • 02

    May

  • 02

    May

  • 02

    May

  • 02

    May

  • 02

    May

  • 02

    May

  • 02

    May

  • 02

    May

  • 02

    May

  • 03

    May

  • 03

    May

  • 03

    May

  • 03

    May

  • 03

    May

  • 03

    May

  • 04

    May

  • 04

    May

  • 04

    May

  • 05

    May

  • 05

    May

  • 08

    May

  • 08

    May

  • 09

    May

  • 09

    May

  • 09

    May

  • 10

    May

  • 16

    May

  • 16

    May

  • 16

    May

  • 16

    May

  • 17

    May

  • 17

    May

  • 18

    May

  • 22

    May

  • 23

    May

  • 23

    May

  • 24

    May

  • 25

    May

  • 31

    May

  • 05

    Jun

  • 06

    Jun

  • 13

    Jun

KBR

KBR

$14.05

-1.43 (-9.24%)

18:47
04/28/17
04/28
18:47
04/28/17
18:47
Hot Stocks
KBR issues statement on SFO investigation »

KBR made the following…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.